Cancer
At the Kolling Institute, our cancer research aims to identify and overcome the factors that drive cancer development so that we can improve patient outcomes. We have a number of cancer research teams with different expertise, specialising in chemotherapy resistance, immunotherapies, genetics, epigenetics, diagnostic services and clinical trials. Importantly, these teams have access to an active tissue bank and the latest equipment.
Our cancer research rapidly implements laboratory findings into clinical practice and is supported by the Cancer Institute Translational Centre, Sydney Vital. By bringing together research scientists, clinicians and allied health professionals, we are able to combine innovative and cutting edge research with personalised treatment strategies for cancer patients.
Find out more about:
Bill Walsh Translational Cancer Research Laboratory
Bowel Cancer and Biomarker Research Lab
Breast Cancer Research
Cancer Genetics Laboratory
Events, News and Seminars
Common, easily accessible medication could reduce severe COVID-19 symptoms
Posted on: 02 July, 2020
A group of blood pressure medications may hold the key to better outcomes for those with COVID-19, m..... Read more
Category: New Treatment
New research challenges long-held views about high heels and joint pain
Posted on: 02 July, 2020
New research has produced a surprising result, indicating high heel shoes may not be a problem for t..... Read more
Category: Research Excellence
Congratulations Professor Rob Baxter
Posted on: 16 June, 2020
Former Kolling Institute director Professor Rob Baxter received an Order of Australia medal in the Q..... Read more
Category: Awards